Moreover, SPP1 expression was dramatically upregulated in tumor-associated macrophages (TAMs) following ICBs, and SPP1+ TAMs correlated with adverse clinical outcomes in an independent cohort of 264 patients with ICC. The gene discussed is SPP1; the disease is neoplasm.